Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021

Study Title

A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021

Teva Identifier

DR-DSG-302

ClinicalTrials.gov Identifier

NCT00544882

Study Status

Completed

Trial Condition(s)

Healthy

Interventions

Drug: DR-1021 | Drug: Mircetteֲ® | Drug: Karivaֲ®

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
female icon for clinical trials

Key Participation Requirements

Gender

Female

Age Range

18 Years to 35 Years

Trial Duration

10/01/2007 - 03/01/2008

Phase

Phase 3

Study Type

Interventional